Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2008
05/14/2008EP1921073A1 1,2,4-Triazole derivatives as sigma receptor inhibitors
05/14/2008EP1921071A1 1,2,3- triazole derivatives as sigma receptor inhibitors
05/14/2008EP1921064A1 Pharmaceutical composition
05/14/2008EP1920780A1 Peptide compounds for the treatment of hyperexcitability disorders
05/14/2008EP1920777A1 Extraction method for the fractioned preparation and separation of plant ingredients and use thereof
05/14/2008EP1919979A1 Polymer conjugates of k-252a and derivatives thereof
05/14/2008EP1919911A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists
05/14/2008EP1919908A1 Triazole derivatives as modulators of dopamine d3 receptors
05/14/2008EP1919907A2 Heterocyclic compound
05/14/2008EP1919901A1 Substituted piperazines as metabotropic glutamate receptor antagonists
05/14/2008EP1919883A1 N-oxides as prodrugs of piperazine&piperidine derivatives
05/14/2008EP1919877A1 P38 map kinase inhibitors and methods for using the same
05/14/2008EP1919869A1 Novel indole compounds
05/14/2008EP1919506A1 Peptide conjugate for oral delivery of hydrophilic peptide analgesics
05/14/2008EP1919482A1 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
05/14/2008EP1919481A2 Therapy for neurological diseases
05/14/2008EP1919476A2 Benztropine compounds and uses thereof as dopamine uptake inhibitors
05/14/2008EP1919473A1 Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use of same
05/14/2008EP1919465A2 Gsk-3 inhibitors
05/14/2008EP1919304A1 Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain
05/14/2008EP1824852B1 1,2,3,3a,8,8a-hexahydro-2,7a-diaza-cyclopenta[a]inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulating cholinergic function and in the treatment of addictive disorders
05/14/2008EP1635833B1 Combination of opioids and a piperazine derivative for the treatment of pain
05/14/2008EP1633440B1 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
05/14/2008EP1606277B1 Imidazol-4-yl-ethynyl-pyridine derivatives
05/14/2008EP1465900B1 Rho-kinase inhibitors
05/14/2008EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors
05/14/2008EP1390023B1 Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds
05/14/2008EP1267867B1 Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists
05/14/2008EP1235934B1 Screening method for candidate drugs
05/14/2008EP1171159B1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
05/14/2008CN201058075Y Pain relieving tape for bosom urosome tumour patient
05/14/2008CN101180299A Acetylenyl-pyrazolo-pvrimidine derivatives as MGLUR2 antagonists
05/14/2008CN101180283A Dihydrobenzofuran derivatives and uses thereof
05/14/2008CN101180276A 2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
05/14/2008CN101180267A Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof
05/14/2008CN101180056A Agent for treating involuntary movement
05/14/2008CN101180054A Medical uses of 39-desmethoxyrapamycin and analogues thereof
05/14/2008CN101180046A Stable tablet containing droxidopa
05/14/2008CN101180044A Combination of egf/ghrp-6 for neuroregeneration of central nervous system
05/14/2008CN101180041A Therapeutic agent for sensory abnormality
05/14/2008CN101177427A Compound polycrystalline type alpha and solvate for hypnotism, preparation method and combination including the same
05/14/2008CN101176774A Preparations capable of accelerating somnus and improving somnus quality as well as preparation method thereof
05/14/2008CN101176773A Plaster for curing neurotic facial palsy and preparation method thereof
05/14/2008CN101176742A Pharmaceutical composition for curing cough
05/14/2008CN101176740A Method for extracting angelica essential oil
05/14/2008CN101176735A Composite preparations for curing schemic brain damage
05/14/2008CN101176729A Huperzine dropping pills and preparation method thereof
05/14/2008CN101176563A Lecithin sesame gruel improving anamnesis and learning capacity
05/14/2008CN100387597C Amide substituted imidazopyridines
05/14/2008CN100387594C Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5
05/14/2008CN100387576C Substituted phenylalkanoic acid derivatives and use thereof
05/14/2008CN100387269C Schisandra chinensis soft capsule
05/14/2008CN100387243C Quality control method of ixeris sonchifolia injection
05/14/2008CN100387242C American ginseng and royal jelly soft capsule
05/14/2008CN100387235C New pharmaceutical use of echinacoside
05/14/2008CN100387230C Pharmaceutical combination prepared by cannabis extract
05/14/2008CN100387228C Injectable methadone, partial opioid-opium agonist or opioid-opium antagonist particle composition, and use thereof
05/13/2008US7371896 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
05/13/2008US7371895 antiinflammatory agents; autoimmune and cardiovascular disorders; atherosclerosis, rheumatoid arthritis, hyperlipemia; better water solubility increases the bioavailability and pharmacokinetics
05/13/2008US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl
05/13/2008US7371853 Ring structuresC6.C6.C14N2O, C6.C6.C15N2O, C6.C6.C16N2O and C6.C6.C17N2O
05/13/2008US7371833 Nucleic acid molecules with specific recognition of native PrPSc, production and use
05/13/2008US7371828 Extracellular signal-regulated kinase sequences and methods of production and use
05/13/2008US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction
05/13/2008US7371779 Synergistic compositions of N-acylhomoserine lactones and 4-quinolones
05/13/2008US7371771 Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase
05/13/2008US7371767 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
05/13/2008US7371756 Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
05/13/2008US7371754 Tyrosine kinase inhibitors
05/13/2008US7371752 such as 5-(4-Fluorophenyl)-7-[(2-pyridyl)-methyloxy]-thieno[3,2-b]pyridine, used as prodrugs or antagonists for GABA receptors, in diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and epileptic disorders, as cognition activators and as antidotes to benzodiazepines
05/13/2008US7371748 Benzothiazole derivatives
05/13/2008US7371747 Cyanoalkylamino derivatives as protease inhibitors
05/13/2008US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene
05/13/2008US7371535 Detect binding with cells transfected with DNA
05/13/2008US7371406 for needles comprising time release microparticles containing risperidones, glycolic acid-lactic acid copolymer binders, and high viscosity aqueous fluids (containing sodium carboxymethyl cellulose as modifier)
05/13/2008US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders
05/13/2008US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability
05/13/2008US7371370 Using colony stimulating factor comprising amino acid sequence variation as therapeutic tools in treatment and prevention of hematopoietic, neurological or reproduction disorders
05/13/2008CA2468449C Improvements in benzodiazepine treatment by cholinesterase inhibitors
05/13/2008CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89)
05/13/2008CA2410234C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis
05/13/2008CA2367136C Use of xenon for treating neurointoxications
05/13/2008CA2327395C New imidazotriazolopyrimidines, processes for preparing them and their use as pharmaceutical compositions
05/13/2008CA2299909C Therapeutic agent for neurodegenerative disorders
05/13/2008CA2216658C Hapten-carrier conjugates for use in drug-abuse therapy
05/13/2008CA2212058C Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease
05/13/2008CA2196995C Spiro-azabicyclic compounds useful in therapy
05/08/2008WO2008055112A2 Methods of treating autism and autism spectrum disorders
05/08/2008WO2008055022A2 Carbamate compounds for use in treating depression
05/08/2008WO2008054984A1 Treatment of pervasive developmental disorders
05/08/2008WO2008054292A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain.
05/08/2008WO2008054291A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain.
05/08/2008WO2008054252A1 Pharmacologically active n,n'-substituted 3,7-diazabicyclo [3.3.1] nonanes, pharmaceutical compositions based thereon and a method for the use thereof
05/08/2008WO2008054171A1 Omega conotoxins
05/08/2008WO2008053962A1 Method for identification of compound having antianxiety effect
05/08/2008WO2008053764A1 Anti-prion active compound, anti-prion active agent, and method for inhibition of the production of abnormal prion protein
05/08/2008WO2008053352A2 Phenylpropionamide compounds and the use thereof
05/08/2008WO2008053326A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
05/08/2008WO2008053325A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
05/08/2008WO2008053301A2 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
1 ... 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 ... 1833